???global.info.a_carregar???
I am a Biologist and graduated at the University of Bonn, Germany, in 1989, and obtained my PhD at the German Cancer Research Centre in Heidelberg. Following a post-doctoral research in Lisbon, I was recruited by the National Institute of Health Dr. Ricardo Jorge, in Lisbon, where I became an independent group leader in 1999. Since 2003, I am a staff Principal Researcher at Instituto Nacional de Saúde Doutor Ricardo Jorge, and my current bibliographic data are 80 international peer reviewed publications, an h-index of 31 with over 3321 citations (according to Researcher ID (G-9335-2012) metrics in January 2024), 8 concluded PhD thesis supervisions, and PI of over 20 research grants over the last 25 years. My main research interest is signal transduction pathways in colon cancer. A major focus is the analysis of signalling pathways in cultured colorectal cancer cells, in particular concerning the small GTPases RAC1 or RAC1B, and the WNK family of protein kinases. Key methodological approaches include the analysis of RNA and protein expression, protein kinase and GTPase activity assays, protein complex analysis, and confocal microscopy.
Read full resume ↓
Identification

Personal identification

Full name
Peter Jordan

Citation names

  • Jordan, Peter

Author identifiers

Ciência ID
A01A-1F55-88DB
ORCID iD
0000-0002-1425-9211

Telephones

Telephone
  • 217519380 (Professional)

Addresses

  • Avenida Padre Cruz, 1649-016, Lisboa, Lisboa, Portugal (Professional)

Knowledge fields

  • Natural sciences - Biological Sciences - Cell Biology

Languages

Language Speaking Reading Writing Listening Peer-review
Germanic languages (Other) (Mother tongue)
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Portuguese Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
French Advanced (C1) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2)
Education
Degree Classification
2009/10/08
Concluded
 Novel Signalling molecules involved in cancer and rare genetic diseases (Título de Habilitação de Coordenação Científica)
Major in Human Genetics
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 aprovado
1990/03 - 1993/06
Concluded
 Biology (Doktor (PhD))
Ruprecht Karls Universität Heidelberg HIP Zellbiologie, Germany
"Identification of phosphoproteíns pp100 e pp120, ubiquitous substrates of an ecto-proteín knase " (THESIS/DISSERTATION)
 very good
1983/09 - 1989/09
Concluded
 Biology (Master)
Rheinische Friedrich Wilhelms Universität Bonn Fachgruppe Biologie, Germany
"Extraction and Characterization of vanadium-dependent bromoperoxidases in the brown algae Laminaria digitata " (THESIS/DISSERTATION)
 suma cum laude
Affiliation

Science

Category
Host institution 		Employer
2003/06 - Current Principal Investigator (Research) Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
1999/10 - 2003/06 Invited Principal Investigator (Research) Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
1996/10 - 1999/09 Contracted Researcher (Research) Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
1993/09 - 1996/09 Postdoc (Research) Universidade de Lisboa Faculdade de Medicina, Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal
1990/03/01 - 1993/06/23 Researcher (Research) Deutsches Krebsforschungszentrum, Germany
Ruprecht Karls Universität Heidelberg Fakultät für Biowissenschaften, Germany
1989/10 - 1990/02 Visiting Researcher (Research) Heinrich Hertz Stiftung, Germany
Station Biologique de Roscoff, France

Teaching in Higher Education

Category
Host institution 		Employer
2014/04 - Current Invited Associate Professor (University Teacher) Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
Universidade de Lisboa Faculdade de Ciências, Portugal
Projects

Contract

Designation Funders
2022/05 - 2029/04 EU Partnership for the Assessment of Risks from Chemicals (PARC)
PARC
Researcher
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
Ongoing
2018/10/04 - 2022/10/03 Mecanismos Celulares e Moleculares de Toxicidade dos Nanomateriais Ingeridos
PTDC/SAU-PUB/29481/2017
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2018/10/04 - 2022/09 Microenvironmental effects on alternative splicing in malignant progression of colorectal tumor cells
PTDC/BIA-MOL/28386/2017
Researcher
Fundação para a Ciência e a Tecnologia, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2018/10 - 2022/09 Novel signaling pathways regulating cell surface retention of epithelial choride transport proteins
PTDF/BIA-CEL/28408/2017
Principal investigator
Fundação para a Ciência e a Tecnologia, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2018/10/04 - 2021/10/03 Uma abordagem de toxicologia preditiva para a caracterização dos potenciais efeitos respiratórios de fibras de nanocelulose funcionalizadas num sistema de co-cultura
PTDC/SAU-PUB/32587/2017
Universidade de Coimbra, Portugal

RAIZ Instituto de Investigação da Floresta e Papel, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2019/01/01 - 2019/12/31 Instituto de Biosistemas & Ciências Integrativas
UID/Multi/04046/2019
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Universidade do Minho, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal

FCiênciasID Associação para a Investigação e Desenvolvimento de Ciências, Portugal

Universidade de Lisboa Faculdade de Ciências, Portugal

Universidade de Lisboa Instituto de Biossistemas e Ciências Integrativas, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2016/01 - 2019/12 Perturbation of the intestinal barrier function in inflammatory blowel disease: tole of the Rac1b/cytokine axis
06/2013
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 universidade do Porto - grupo de estudo da doença inflamatória intestinal
Ongoing
2015/07 - 2018/05 Tumor cell plasticity through alternative splicing in response to a 3D pro-inflammatory microenvironment,
cancro 2014
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Maratona da Saúde
Concluded
2016/01 - 2017/12 Protein networks stabilizing CFTR at the plasma membrane
cc6202-P0.b
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Universidade de Lisboa Instituto de Biossistemas e Ciências Integrativas
Concluded
2012/01 - 2014/12 New insights into the regulation of insulin-sensitive glucose transporters by protein kinases
117236
Provided by PTCRIS: 117236
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2011/02 - 2014/04 Potential predictive biomarkers of anti-RTKs therapy response in gliomas: An in vitro and in vivo study
Provided by PTCRIS: 114549
114549
Researcher
Universidade do Minho, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2012/03/01 - 2013/08 A novel Rac1/PAK1/BCL-6 pathway to regulate gene expression: genome-wide screening for target genes
info:eu-repo/grantAgreement/FCT/3599-PPCDT/119586/PT
Researcher
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2012/03 - 2013/08 A novel signalling pathway possibly involved in renal salt handling and hypertension
119782
Provided by PTCRIS: 119782
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
2010/01/01 - 2012/02/29 Papel da proteína cinase WNK2 como gene supressor de gliomas malignos
PTDC/SAU-OBD/100079/2008
Universidade do Minho, Portugal

Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2010/01 - 2012/02 Role of protein kinase WNK2 as a tumour suppressor gene in malignant gliomas
100079
Provided by PTCRIS: 100079
Principal investigator
Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2009/01 - 2011/12 Effects of inflammation on Rac1b, a novel therapeutic target in colorectal tumours
96495
Principal investigator
Fundação Calouste Gulbenkian
Concluded
2007/08/01 - 2010/11/30 Role of novel regulatory mechanisms in the loss of E-cadherin expression
PTDC/SAU-GMG/72168/2006
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2007/08 - 2010/11 Papel de novos mechanismos regulatórios na perda de expressão da caderina-E
72168
Provided by PTCRIS: 72168
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
2007/01 - 2009/12 Molecular pathways involved in Gordon syndrome, a familial hypertension disease
82304
Provided by PTCRIS: 82304
Principal investigator
Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2007/01 - 2008/11 Implications for tumor development of Rac1/Rac1b-modulated gene transcription
82401
Provided by PTCRIS: 82401
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2007/01 - 2008/07 Role of WNK protein kinases in endosomal traffic
82124
Provided by PTCRIS: 82124
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2006/01 - 2007/06 Molecular pathways involved in Gordon syndrome, a familial hypertension disease
56439
Provided by PTCRIS: 56439
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2005/08 - 2007/06 Implications for tumor development of Rac1/Rac1b-modulated gene transcription
57660
Provided by PTCRIS: 57660
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2005/08 - 2007/06 Role of WNK protein kinases in endosomal traffic
Provided by PTCRIS: 56294
56294
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
2003/11/01 - 2006/11/15 Regulation of alternative splicing of the small GTPase Rac1
info:eu-repo/grantAgreement/FCT/POCI/47546/PT
Principal investigator
Fundação para a Ciência e a Tecnologia
Concluded
2005 - 2006 Microscopia confocal para a análise de doenças genéticas
REEQ/791
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2004/04 - 2005/08 Alternative splicing confers novel signalling properties to Rac1, a role in colorectal tumour progression
04-008
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Association for International Cancer Research
Concluded
2001/04 - 2004/04 Full-length cDNA cloning and biochemical characterization of a novel human protein kinase
BME/33221/99
Principal investigator
Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2000/10 - 2004/03 A novel human splice variant of the small GTPase Rac1: characterization of its role in signalling and cell adhesion
CBO/32976/99
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
1999/03 - 2000/03 Characterization of a novel splice variant of the small GTPase Rac1, a member of the ras superfamily
SAU/14136/98
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
1997/11 - 2000/02 Cloning of novel serine/threonine protein kinases expressed in human colonic epithelial cells
SAU/107/96
Principal investigator
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
Outputs

Publications

Book chapter
  1. Matos, Paulo; Pereira, JFS; Jordan, Peter. "Targeting cancer by using nanoparticles to modulate RHO GTPase signaling". In Nanotoxicology in safety assessment of nanomaterials. Springer Nature, 2022.
    In press
  2. Jordan, Peter; Vânia Gonçalves; Sara Fernandes; Tânia Marques; Marcelo Pereira; Margarida Gama-Carvalho. "Networks of mRNA Processing and Alternative Splicing Regulation in Health and Disease". 2019.
    Published • 10.1007/978-3-030-19966-1_1
  3. Jordan, Peter. "Colorectal Cancer Subtypes - The Current Portrait". In Targeted Therapy of Colorectal Cancer Subtypes, 1-6. Springer International Publishing, 2018.
    Published • 10.1007/978-3-030-02771-1_1
  4. Matos, Paulo; Jordan, Peter. "Targeting Colon Cancers with Mutated BRAF and Microsatellite Instability". In Targeted Therapy of Colorectal Cancer Subtypes, 7-21. Springer International Publishing, 2018.
    Published • 10.1007/978-3-030-02771-1_2
  5. Matos, Paulo; Gonçalves, Vânia; Jordan, Peter. "Therapeutic Approaches Targeting the Serrated Pathway of Colorectal Cancer Characterized by Mutation in the BRAF Gene and Overexpression of GTPase Rac1b". In Therapeutic Targets for Inflammation and Cancer, 233-255. WORLD SCIENTIFIC, 2017.
    Published • 10.1142/9789813148574_0011
  6. Jordan, Peter; Vânia Gonçalves. "The deleterious effect of missense mutations on pre-mRNA splicing". In Advances in Genetics Research, 141-152. Nova Science Publisher, 2011.
    Published
  7. Jordan, Peter; Moniz, Sónia. "WNK kinase signalling in cancer biology". In Emerging Signaling Pathways in Tumor Biology, 43-71. kerala, India: Transworld Research Network,, 2010.
    Published
  8. Jordan, Peter; Gonçalves, Vânia; Matos, Paulo. "Alternative splicing changes regulation and signalling properties of the small GTPase Rac1". In Alternative Splicing and Cancer, 45-65. Kerala, India: Transworld Research Network, 2006.
    Published
Conference paper
  1. Henriques, A. A.; Matos, P.; Jordan, P.. "Regulation of glucose transporters by protein kinases in cancer cells". Paper presented in ESMO 2017- European Society of Medical Oncology, Madrid, 2017.
    Published
  2. Goncalves, V.; Matos, P.; Henriques, A. A.; Pereira, J.; Jordan, P.. "Signal transduction pathways regulating alternative splicing of tumor-related RAC1b". Paper presented in ESMO 2017- European Society of Medical Oncology, Madrid, 2017.
    Published
  3. Barros, P.; Amaral, A. J.; Abrantes, L. B.; Oliveira, T.; Louro, H.; Silva, M. J.; Jordan, P.; Gama-Carvalho, M.; Matos, P.. "Stimulation of RAC1/PAK1 signalling upregulates DNA damage repair genes via the BCL6/STAT5-switch". Madrid, 2017.
    Published
Conference poster
  1. Jordan, Peter. "More than 50 poster authored in the last 8 years". Paper presented in various national and international meetings, 2015.
Edited book
  1. Jordan, Peter. Targeted Therapy of Colorectal Cancer Subtypes. Springer International Publishing. 2018.
    Published • 10.1007/978-3-030-02771-1 • Editor
Journal article
  1. Patrícia Barros; Ana M. Matos; Paulo Matos; Peter Jordan. "YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1". Biomolecules (2023): https://doi.org/10.3390/biom13060949.
    10.3390/biom13060949
  2. Dora Rolo; Ricardo Assunção; Célia Ventura; Paula Alvito; Lídia Gonçalves; Carla Martins; Ana Bettencourt; et al. "Adverse Outcome Pathways Associated with the Ingestion of Titanium Dioxide Nanoparticles—A Systematic Review". Nanomaterials (2022): https://doi.org/10.3390/nano12193275.
    10.3390/nano12193275
  3. Joana F. S. Pereira; Cláudia Bessa; Paulo Matos; Peter Jordan. "Pro-Inflammatory Cytokines Trigger the Overexpression of Tumour-Related Splice Variant RAC1B in Polarized Colorectal Cells". Cancers 14 6 (2022): 1393-1393. https://doi.org/10.3390/cancers14061393.
    10.3390/cancers14061393
  4. Matos, Ana M.; Jordan, Peter; Matos, Paulo. "Treatment of Polarized Cystic Fibrosis Airway Cells With HGF Prevents VX-661-Rescued F508del-CFTR Destabilization Caused by Prolonged Co-exposure to VX-770". Frontiers in Molecular Biosciences 8 (2021): http://dx.doi.org/10.3389/fmolb.2021.812101.
    Open access • Published • 10.3389/fmolb.2021.812101
  5. Alves, Ana Catarina; Azevedo, Sílvia; Benito-Vicente, Asier; Graça, Rafael; Galicia-Garcia, Unai; Barros, Patrícia; Jordan, Peter; Martin, Cesar; Bourbon, Mafalda. "LDLR variants functional characterization: Contribution to variant classification". Atherosclerosis 329 (2021): 14-21. http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.001.
    Published • 10.1016/j.atherosclerosis.2021.06.001
  6. Joana F. S. Pereira; Peter Jordan; Paulo Matos. "A Signaling View into the Inflammatory Tumor Microenvironment". Immuno (2021): https://doi.org/10.3390/immuno1020007.
    10.3390/immuno1020007
  7. Cláudia Bessa; Paulo Matos; Peter Jordan; Vânia Gonçalves. "Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics". International Journal of Molecular Sciences 21 23 (2020): 9032-9032. https://doi.org/10.3390/ijms21239032.
    Open access • Published • 10.3390/ijms21239032
  8. Ventura, Célia; Pereira, Joana F. S.; Matos, Paulo; Marques, Bárbara; Jordan, Peter; Sousa-Uva, António; Silva, Maria João. "Cytotoxicity and genotoxicity of MWCNT-7 and crocidolite: assessment in alveolar epithelial cells versus their coculture with monocyte-derived macrophages". Nanotoxicology (2020): 1-25. http://dx.doi.org/10.1080/17435390.2019.1695975.
    10.1080/17435390.2019.1695975
  9. Ana Laura Vieira Alves; Angela Margarida Costa; Martinho O; Da Silva, V.D.; Peter Jordan; viviane silva; Reis RM. "WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell Line". Cells (2020): https://www.mdpi.com/2073-4409/9/2/485.
    10.3390/cells9020485
  10. Cláudia Almeida Loureiro; Francisco R. Pinto; Patrícia Barros; Paulo Matos; Peter Jordan. "A SYK/SHC1 pathway regulates the amount of CFTR in the plasma membrane". Cellular and Molecular Life Sciences (2020): https://doi.org/10.1007/s00018-020-03448-4.
    10.1007/s00018-020-03448-4
  11. Henriques, Andreia F.A.; Matos, Paulo; Carvalho, Ana Sofia; Azkargorta, Mikel; Elortza, Felix; Matthiesen, Rune; Jordan, Peter. "WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1". Archives of Biochemistry and Biophysics 679 (2020): 108223. http://dx.doi.org/10.1016/j.abb.2019.108223.
    In press • 10.1016/j.abb.2019.108223
  12. Jordan, Peter; Gonçalves, Vânia; Matos, Paulo; Henriques, Andreia A. "Ibuprofen disrupts a WNK1/GSK3ß/SRPK1 protein complex required for expression of tumor-related splice variant RAC1B in colorectal cells". Oncotarget 11 (2020): 4421-4437.
    Published • 10.18632/oncotarget.27816
  13. Jordan, Peter. "Tyrosine phosphorylation modulates cell surface expression of chloride cotransporters NKCC2 and KCC3". Archives of Biochemistry and Biophysics (2019): http://dx.doi.org/10.1016/j.abb.2019.05.022.
    Published • 10.1016/j.abb.2019.05.022
  14. Jordan, Peter. "Network Biology Identifies Novel Regulators of CFTR Trafficking and Membrane Stability". Frontiers in Pharmacology (2019): http://dx.doi.org/10.3389/fphar.2019.00619.
    Published • 10.3389/fphar.2019.00619
  15. Jordan, Peter; Gonçalves, Vânia; Matos, Paulo. "A new twist to Ibuprofen: alternative action in alternative splicing.". European Medical Journal 4 2 (2019): 64-71. https://www.emjreviews.com/oncology/article/a-new-twist-to-ibuprofen-alternative-action-in-alternative-splicing/.
    Published
  16. Larissa Kotelevets; Francine Walker; Godefroy Mamadou; Thérèse Lehy; Peter Jordan; Eric Chastre. "The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression". Oncogene (2018): https://doi.org/10.1038/s41388-018-0389-7.
    10.1038/s41388-018-0389-7
  17. Goncalves, Vania; Pereira, Joana F S; Jordan, Peter. "Signaling Pathways Driving Aberrant Splicing in Cancer Cells.". Genes 9 1 (2018): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:29286307&KeyUID=MEDLINE:29286307.
    10.3390/genes9010009
  18. Matos, A. M.; Gomes-Duarte, A.; Faria, M.; Barros, P.; Jordan, P.; Amaral, M. D.; Matos, P.; et al. "Prolonged co-treatment with HGF sustains epithelial integrity and improves pharmacological rescue of Phe508del-CFTR". Sci Rep 8 1 (2018): 13026-13026. https://www.ncbi.nlm.nih.gov/pubmed/30158635.
    10.1038/s41598-018-31514-2
  19. Joana F. S. Pereira; Nikhil T. Awatade; Cláudia A. Loureiro; Paulo Matos; Margarida D. Amaral; Peter Jordan. "The third dimension: new developments in cell culture models for colorectal research". Cellular and Molecular Life Sciences (2016): http://dx.doi.org/10.1007/s00018-016-2258-2.
    10.1007/s00018-016-2258-2
  20. Matos P; Gonçalves V; Jordan P. "Targeting the serrated pathway of colorectal cancer with mutation in BRAF.". Biochim BioPhys Acta -Rev Cancer 1866, (2016): 51-56. http://europepmc.org/abstract/med/27345584.
    Published • 10.1016/j.bbcan.2016.06.003
  21. Farinha CM; Swiatecka-Urban A; Brautigan DL; Jordan P. "Regulatory Crosstalk by Protein Kinases on CFTR Trafficking and Activity.". Front Chem 4:1 (2016): http://europepmc.org/abstract/med/26835446.
    Published • 10.3389/fchem.2016.00001
  22. Jordan, Peter. "Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells". Cancer Letters (2015):
    10.1016/j.canlet.2015.08.027
  23. Matos L; Gonçalves V; Pinto E; Laranjeira F; Prata MJ; Jordan P; Desviat LR; Pérez B; Alves S. "Functional analysis of splicing mutations in the IDS gene and the use of antisense oligonucleotides to exploit an alternative therapy for MPS II.". Biochim Biophys Acta 1852 (2015): 2717-2721. http://europepmc.org/abstract/med/26407519.
    Published • 10.1016/j.bbadis.2015.09.011
  24. Costa AM; Pinto F; Martinho O; Oliveira MJ; Jordan P; Reis RM. "Silencing of the tumor suppressor gene WNK2 is associated with upregulation of MMP2 and JNK in gliomas.". Oncotarget 6 (2015): 1422-1434. http://europepmc.org/abstract/med/25596741.
  25. Vânia Gonçalves; Peter Jordan. "Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology". BioMed Research International 2015 (2015): 1-10. http://dx.doi.org/10.1155/2015/287048.
    10.1155/2015/287048
  26. Claudia Ghigna; Luca Cartegni; Peter Jordan; Maria Paola Paronetto. "Posttranscriptional Regulation and RNA Binding Proteins in Cancer Biology". BioMed Research International 2015 (2015): 1-2. http://dx.doi.org/10.1155/2015/897821.
    Published • 10.1155/2015/897821 • Editor
  27. Matos P; Jordan P. "Beyond COX-inhibition: 'side-effects' of ibuprofen on neoplastic development and progression.". Curr Pharm Design 21 (2015): 2978-2982. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000356081900008&KeyUID=WOS:000356081900008.
    Published • 10.2174/1381612821666150514104608
  28. Matos, Liliana; Goncalves, Vania; Pinto, Eugenia; Laranjeira, Francisco; Prata, Maria Joao; Jordan, Peter; Desviat, Lourdes R; Perez, Belen; Alves, Sandra. "Data in support of a functional analysis of splicing mutations in the IDS gene and the use of antisense oligonucleotides to exploit an alternative therapy for MPS II.". Data in brief 5 (2015): 810-7. https://pubmed.ncbi.nlm.nih.gov/26693516/.
    10.1016/j.dib.2015.10.011
  29. Peter Jordan. "Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells". RNA (2014): http://www.rnajournal.org/cgi/pmidlookup?view=long&pmid=24550521.
    10.1261/rna.041376.113
  30. Matos L; Canals I; Dridi L; Choi Y; Prata MJ; Jordan P; Desviat LR; et al. "Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations.". Orphanet J Rare Dis 9 (2014): 180. http://europepmc.org/abstract/med/25491247.
    Published • 10.1186/s13023-014-0180-y
  31. Moniz, S.; Martinho, O.; Pinto, F.; Sousa, B.; Loureiro, C.; Oliveira, M.J.; Moita, L.F.; et al. "Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness". Human Molecular Genetics 22 1 (2013): 84-95. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871200220&partnerID=MN8TOARS.
    Published • 10.1093/hmg/dds405
  32. Matos, P.; Kotelevets, L.; Gonçalves, V.; Henriques, A.; Zerbib, P.; Moyer, M.P.; Chastre, E.; Jordan, P.. "Ibuprofen inhibits colitis-induced overexpression of tumor- related Rac1b". Neoplasia (United States) 15 1 (2013): 102-111. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873020742&partnerID=MN8TOARS.
    10.1593/neo.121890
  33. Vieira, L.; Vaz, A.; Matos, P.; Ambrósio, A.P.; Nogueira, M.; Marques, B.; Pereira, A.M.; Jordan, P.; da Silva, M.G.. "Three-way translocation (X;20;16)(p11;q13;q23) in essential thrombocythemia implicates NFATC2 in dysregulation of CSF2 expression and megakaryocyte proliferation". Genes Chromosomes and Cancer 51 12 (2012): 1093-1108. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867233450&partnerID=MN8TOARS.
    10.1002/gcc.21994
  34. Pinheiro, H.; Carvalho, J.; Oliveira, P.; Ferreira, D.; Pinto, M.T.; Osoquot;rio, H.; Licastro, D.; et al. "Transcription initiation arising from E-cadherin/CDH1 intron2: A novel protein isoform that increases gastric cancer cell invasion and angiogenesis". Human Molecular Genetics 21 19 (2012): 4253-4269. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866408689&partnerID=MN8TOARS.
    10.1093/hmg/dds248
  35. Barros, P.; Lam, E.W.-F.; Jordan, P.; Matos, P.. "Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters". Nucleic Acids Research 40 16 (2012): 7776-7787. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870572352&partnerID=MN8TOARS.
    Published • 10.1093/nar/gks571
  36. Mendes, A.I.; Mascarenhas, M.R.; Matos, S.; Sousa, I.; Ferreira, J.; Barbosa, A.P.; Bicho, M.; Jordan, P.. "A WNK4 gene variant relates to osteoporosis and not to hypertension in the Portuguese population". Molecular Genetics and Metabolism 102 4 (2011): 465-469. http://www.scopus.com/inward/record.url?eid=2-s2.0-79952623807&partnerID=MN8TOARS.
    10.1016/j.ymgme.2010.12.010
  37. Mendes, Ana Isabel; Matos, Paulo; Moniz, Sonia; Luz, Simao; Amaral, Margarida D.; Farinha, Carlos M.; Jordan, Peter. "Antagonistic Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Cell Surface Expression by Protein Kinases WNK4 and Spleen Tyrosine Kinase". Molecular and Cellular Biology 31 19 (2011): 4076-4086. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000294710100015&KeyUID=WOS:000294710100015.
    Published • 10.1128/mcb.05152-11
  38. Luz, S.; Kongsupho, P.; Mendes, A.I.; Romeiras, F.; Sousa, M.; Schreiber, R.; Matos, P.; et al. "Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase a-induced activity". Molecular and Cellular Biology 31 22 (2011): 4392-4404. http://www.scopus.com/inward/record.url?eid=2-s2.0-83255187903&partnerID=MN8TOARS.
    Published • 10.1128/MCB.05517-11
  39. Luz, Simão; Kongsuphol, Patthara; Mendes, Ana Isabel; Romeiras, Francisco; Sousa, Marisa; Schreiber, Rainer; Matos, Paulo; et al. "The contribution of CK2 and spleen tyrosine kinase (SYK) to CFTR trafficking and PKA-induced activity". (2011): http://hdl.handle.net/10400.18/907.
  40. Moniz, S.; Jordan, P.. "Emerging roles for WNK kinases in cancer". Cellular and Molecular Life Sciences 67 8 (2010): 1265-1276. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950604823&partnerID=MN8TOARS.
    10.1007/s00018-010-0261-6
  41. Dias, E.; Matos, P.; Pereira, P.; Batoréu, M.C.C.; Silva, M.J.; Jordan, P.. "Microcystin-LR activates the ERK1/2 kinases and stimulates the proliferation of the monkey kidney-derived cell line Vero-E6". Toxicology in Vitro 24 6 (2010): 1689-1695. http://www.scopus.com/inward/record.url?eid=2-s2.0-77956172500&partnerID=MN8TOARS.
    10.1016/j.tiv.2010.05.018
  42. Mendes, A.I.; Matos, P.; Moniz, S.; Jordan, P.. "Protein kinase WNK1 promotes cell surface expression of glucose transporter GLUT1 by regulating a Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4)-Rab8A complex". Journal of Biological Chemistry 285 50 (2010): 39117-39126. http://www.scopus.com/inward/record.url?eid=2-s2.0-78649807481&partnerID=MN8TOARS.
    10.1074/jbc.M110.159418
  43. Velho, S.; Oliveira, C.; Paredes, J.; Sousa, S.; Leite, M.; Matos, P.; Milanezi, F.; et al. "Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours". Human Molecular Genetics 19 4 (2010): 697-706. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950353937&partnerID=MN8TOARS.
    10.1093/hmg/ddp536
  44. Barros, Patricia; Jordan, Peter; Matos, Paulo. "Rac1 Signaling Modulates BCL-6-Mediated Repression of Gene Transcription". Molecular and Cellular Biology 29 15 (2009): 4156-4166. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000267939400012&KeyUID=WOS:000267939400012.
    Published • 10.1128/mcb.01813-08
  45. Dias, E.; Andrade, M.; Alverca, E.; Pereira, P.; Batoréu, M.C.C.; Jordan, P.; Silva, M.J.. "Comparative study of the cytotoxic effect of microcistin-LR and purified extracts from Microcystis aeruginosa on a kidney cell line". Toxicon 53 5 (2009): 487-495. http://www.scopus.com/inward/record.url?eid=2-s2.0-61449170919&partnerID=MN8TOARS.
    10.1016/j.toxicon.2009.01.029
  46. Alverca, E.; Andrade, M.; Dias, E.; Sam Bento, F.; Batoréu, M.C.C.; Jordan, P.; Silva, M.J.; Pereira, P.. "Morphological and ultrastructural effects of microcystin-LR from Microcystis aeruginosa extract on a kidney cell line". Toxicon 54 3 (2009): 283-294. http://www.scopus.com/inward/record.url?eid=2-s2.0-67649414226&partnerID=MN8TOARS.
    10.1016/j.toxicon.2009.04.014
  47. Gonçalves, V.; Matos, P.; Jordan, P.. "Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways". Human Molecular Genetics 18 19 (2009): 3696-3707. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350782482&partnerID=MN8TOARS.
    10.1093/hmg/ddp317
  48. Gonçalves, V.; Theisen, P.; Antunes, O.; Medeira, A.; Ramos, J.S.; Jordan, P.; Isidro, G.. "A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14". Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 662 1-2 (2009): 33-36. http://www.scopus.com/inward/record.url?eid=2-s2.0-60749118005&partnerID=MN8TOARS.
    10.1016/j.mrfmmm.2008.12.001
  49. Seruca, R.; Velho, S.; Oliveira, C.; Leite, M.; Matos, P.; Jordan, P.. "Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors". Expert Rev Gastroenterol Hepatol 3 1 (2009): 5-9. http://www.ncbi.nlm.nih.gov/pubmed/19210107.
    10.1586/17474124.3.1.5 [pii]10.1586/17474124.3.1.5
  50. Matos, Paulo; Jordan, Peter; Matos, P.; Jordan, P.. "Increased Rac1b expression sustains colorectal tumor cell survival". Molecular Cancer Research 6 7 (2008): 1178-1184. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000257895900010&KeyUID=WOS:000257895900010.
    10.1158/1541-7786.mcr-08-0008
  51. Gonçalves, V.; Matos, P.; Jordan, P.. "The ß-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression". RNA 14 12 (2008): 2538-2549. http://www.scopus.com/inward/record.url?eid=2-s2.0-57049129377&partnerID=MN8TOARS.
    10.1261/rna.1253408
  52. Moniz, S.; Matos, P.; Jordan, P.. "WNK2 modulates MEK1 activity through the Rho GTPase pathway". Cellular Signalling 20 10 (2008): 1762-1768. http://www.scopus.com/inward/record.url?eid=2-s2.0-49549097880&partnerID=MN8TOARS.
    10.1016/j.cellsig.2008.06.002
  53. Vieira, L.; Martinho, A.; Antunes, O.; Silva, E.; Ambrósio, A.P.; Geraldes, M.C.; Nascimento, R.; et al. "Combined molecular diagnosis of b-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction". Diagnostic Molecular Pathology 17 2 (2008): 73-81. http://www.scopus.com/inward/record.url?eid=2-s2.0-47049112999&partnerID=MN8TOARS.
    10.1097/PDM.0b013e31814be9e0
  54. Matos, P.; Oliveira, C.; Velho, S.; Gonçalves, V.; da Costa, L.T.; Moyer, M.P.; Seruca, R.; Jordan, P.. "B-RafV600E Cooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell Survival". Gastroenterology 135 3 (2008): 899-906. http://www.scopus.com/inward/record.url?eid=2-s2.0-51249098983&partnerID=MN8TOARS.
    10.1053/j.gastro.2008.05.052
  55. Moniz, S.; Veríssimo, F.; Matos, P.; Brazão, R.; Silva, E.; Kotevelets, L.; Chastre, E.; Gespach, C.; Jordan, P.. "Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2". Oncogene 26 41 (2007): 6071-6081. http://www.scopus.com/inward/record.url?eid=2-s2.0-34548485789&partnerID=MN8TOARS.
    10.1038/sj.onc.1210706
  56. Veríssimo, F.; Silva, E.; Morris, J.D.; Pepperkok, R.; Jordan, P.. "Protein kinase WNK3 increases cell survival in a caspase-3-dependent pathway". Oncogene 25 30 (2006): 4172-4182. http://www.scopus.com/inward/record.url?eid=2-s2.0-33746058616&partnerID=MN8TOARS.
    10.1038/sj.onc.1209449
  57. Vieira, L.; Sousa, A.C.; Matos, P.; Marques, B.; Alaiz, H.; Ribeiro, M.J.; Braga, P.; Da Silva, M.G.; Jordan, P.. "Three-way translocation involves MLL, MLLT3, and a novel cell cycle control gene, FLJ10374, in the pathogenesis of acute myeloid leukemia with t(9;11;19)(p22;q23;p13.3)". Genes Chromosomes and Cancer 45 5 (2006): 455-469. http://www.scopus.com/inward/record.url?eid=2-s2.0-33645814404&partnerID=MN8TOARS.
    10.1002/gcc.20311
  58. Matos, P.; Jordan, P.. "Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells". Journal of Biological Chemistry 281 19 (2006): 13724-13732. http://www.scopus.com/inward/record.url?eid=2-s2.0-33744965194&partnerID=MN8TOARS.
    10.1074/jbc.M513243200
  59. Matos, P.; Jordan, P.. "Expression of Rac1b stimulates NF-¿B-mediated cell survival and G1/S progression". Experimental Cell Research 305 2 (2005): 292-299. http://www.scopus.com/inward/record.url?eid=2-s2.0-16244378220&partnerID=MN8TOARS.
    10.1016/j.yexcr.2004.12.029
  60. Matos, P.; Collard, J.G.; Jordan, P.. "Tumor-related Alternatively Spliced Rac1b Is Not Regulated by Rho-GDP Dissociation Inhibitors and Exhibits Selective Downstream Signaling". Journal of Biological Chemistry 278 50 (2003): 50442-50448. http://www.scopus.com/inward/record.url?eid=2-s2.0-0347379871&partnerID=MN8TOARS.
    10.1074/jbc.M308215200
  61. Clarke, L.A.; Rebelo, C.S.; Gonçalves, J.; Boavida, M.G.; Jordan, P.. "PCR amplification introduces errors into mononucleotide and dinucleotide repeat sequences". Journal of Clinical Pathology - Molecular Pathology 54 5 (2001): 351-353. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034817160&partnerID=MN8TOARS.
    10.1136/mp.54.5.351
  62. Veríssimo, F.; Jordan, P.. "WNK kinases, a novel protein kinase subfamily in multi-cellular organisms". Oncogene 20 39 (2001): 5562-5569. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035817725&partnerID=MN8TOARS.
    10.1038/sj.onc.1204726
  63. Matos, P.; Skaug, J.; Marques, B.; Beck, S.; Veríssimo, F.; Gespach, C.; Boavida, M.G.; Scherer, S.W.; Jordan, P.. "Small GTPase Rac1: Structure, localization, and expression of the human gene". Biochemical and Biophysical Research Communications 277 3 (2000): 741-751. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034597710&partnerID=MN8TOARS.
    10.1006/bbrc.2000.3743
  64. Clarke, L.A.; Jordan, P.; Boavida, M.G.. "Cell type specificity in alternative splicing of the human mismatch repair gene hMSH2". European Journal of Human Genetics 8 5 (2000): 347-352. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034078917&partnerID=MN8TOARS.
    10.1038/sj.ejhg.5200472
  65. Clarke, L. A.; Veiga, I.; Isidro, G.; Jordan, P.; Ramos, J. S.; Castedo, S.; Boavida, M. G.. "Pathological exon skipping in an HNPCC proband with MLHI splice acceptor site mutation". Genes Chromosomes & Cancer 29 4 (2000): 367-370. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000165063200014&KeyUID=WOS:000165063200014.
    10.1002/1098-2264(2000)9999:9999<::aid-gcc1051>3.0.co;2-v
  66. Jordan, P.; Carmo-Fonseca, M.. "Molecular mechanisms involved in cisplatin cytotoxicity". Cellular and Molecular Life Sciences 57 8-9 (2000): 1229-1235. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000089074300009&KeyUID=WOS:000089074300009.
    10.1007/pl00000762
  67. Jordan, P.; Matos, P.; Veríssimo, F.. "Gene cloning at the computer screen: Possibilities and problems". Biochemical and Biophysical Research Communications 279 3 (2000): 741-743. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034731412&partnerID=MN8TOARS.
    10.1006/bbrc.2000.3901
  68. Jordan, P.; Brazao, R.; Boavida, M. G.; Gespach, C.; Chastre, E.. "Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors". Oncogene 18 48 (1999): 6835-6839. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000083792000028&KeyUID=WOS:000083792000028.
    10.1038/sj.onc.1203233
  69. Jordan, P.; Carmo-Fonseca, M.. "Cisplatin inhibits synthesis of ribosomal RNA in vivo". Nucleic Acids Research 26 12 (1998): 2831-2836. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032526319&partnerID=MN8TOARS.
    10.1093/nar/26.12.2831
  70. Jordan, P.; Cunha, C.; Carmo-Fonseca, M.. "The cdk7-cyclin H-MAT1 complex associated with TFIIH is localized in coiled bodies". Molecular Biology of the Cell 8 7 (1997): 1207-1217. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030793104&partnerID=MN8TOARS.
  71. Jordan, P.; Mannervik, M.; Tora, L.; Carmo-Fonseca, M.. "In vivo evidence that TATA-binding protein/SL1 colocalizes with UBF and RNA polymerase I when rRNA synthesis is either active or inactive". Journal of Cell Biology 133 2 (1996): 225-234. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029914626&partnerID=MN8TOARS.
    10.1083/jcb.133.2.225
  72. Carmo-Fonseca, M.; Cunha, C.; Custódio, N.; Carvalho, C.; Jordan, P.; Ferreira, J.; Parreira, L.. "The topography of chromosomes and genes in the nucleus". Experimental Cell Research 229 2 (1996): 247-252. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030589487&partnerID=MN8TOARS.
    10.1006/excr.1996.0367
  73. Jordan, P.; Kubler, D.. "Autoimmune diseases: Nuclear autoantigens can be found at the cell- surface". Molecular Biology Reports 22 1 (1996): 63-66. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029805584&partnerID=MN8TOARS.
  74. Carvalho, T.; Seeler, J.-S.; Ohman, K.; Jordan, P.; Pettersson, U.; Akusjarvi, G.; Carmo-Fonseca, M.; Dejean, A.. "Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix- associated PML bodies". Journal of Cell Biology 131 1 (1995): 45-56. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029100611&partnerID=MN8TOARS.
    10.1083/jcb.131.1.45
  75. Jordan, P.; Heid, H.; Kinzel, V.; Kübler, D.. "Major cell surface-located protein substrates of an ecto-protein kinase are homologs of known nuclear proteins". Biochemistry 33 49 (1994): 14696-14706. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028558474&partnerID=MN8TOARS.
  76. Schiess, K.; Kaszkin, M.; Jordan, P.; Seidler, L.; Kinzel, V.. "Mobilization of diacylglycerol in intact HeLa cells by exogenous phospholipase C from Cl. perfringens is accompanied by release of fatty acids including arachidonic acid". Biochimica et Biophysica Acta - Molecular Cell Research 1137 1 (1992): 82-94. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026672025&partnerID=MN8TOARS.
    10.1016/0167-4889(92)90104-J
  77. Jordan, P.; Kubler, D.. "Ecto-protein kinase release differs from cleavage by phospholipases of a glycosyl-phosphatidylinositol membrane anchor". Biochemistry International 26 1 (1992): 97-104. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026583904&partnerID=MN8TOARS.
  78. Jordan, P.; Vilter, H.. "Extraction of proteins from material rich in anionic mucilages: Partition and fractionation of vanadate-dependent bromoperoxidases from the brown algae Laminaria digitata and L. Saccharina in aqueous polymer two-phase systems". Biochimica et Biophysica Acta - General Subjects 1073 1 (1991): 98-106. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026079131&partnerID=MN8TOARS.
    10.1016/0304-4165(91)90188-M
  79. Jordan, P.; Vilter, H.. "Native bromoperoxidases do not bind to nitrocellulose: Use of DEAE-cellulose as an alternative in blotting". Electrophoresis 11 8 (1990): 653-655. http://www.scopus.com/inward/record.url?eid=2-s2.0-0025125461&partnerID=MN8TOARS.
    10.1002/elps.1150110814
Activities

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2004 - Current 9 PhD student theses concluded (Paulo Matos-2004, Fátima Veríssimo-2004, Sónia Moniz-2007, Ana Isabel Mendes-2008, Vânia Gonçalves- 2009, Patrícia Barros-2012, Cláudia Loureiro- 2019, Andreia Henriques- 2019; Joana Pereira- 2021)
Supervisor
Universidade de Lisboa Faculdade de Ciências, Portugal
2000 - Current 10 MSc theses supervision: Raquel França Brazão, 2000; Carla Sofia Branquinho Rebelo, 2001; José António Almeida, 2002; Zita Carvalho, 2005; Patrícia Barros, 2007; Bruno Rother Moraes, 2010; Andreia Filipa Almeida Henriques, 2011; Cláudia Almeida Loureiro, 2012; Cláudia Alexandra da Silva Rodrigues, 2018; Telma Rosado, 2021.
Co-supervisor
Universidade de Lisboa, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2024 External opponent in over 25 PhD and 15 MSc defenses
(Thesis) Main arguer
 national students (PhD)
Universidade de Lisboa Faculdade de Ciências, Portugal

Universidade do Porto Faculdade de Medicina, Portugal

Association member

Society Organization name Role
2022/01/01 - 2024/12/31 Elected President of the Portuguese Society of Human Genetics Executive President in 2023; Vice-president in 2022 and 2024

Committee member

Activity description
Role 		Institution / Organization
2017/06 - 2023/12 Elected President of the Scientific Council of the National Health Institute Dr. Ricardo Jorge
Coordinator
 Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2023/02 - Current Scientific coordinator of a course unit on Oncobiology for Master's student Mestrado em Bioquímica e Biomedicina (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal
2014/04 - Current sporadic oncobiologia class teaching Bioquímica (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal

Journal scientific committee

Journal title (ISSN) Publisher
2000 - 2024 Regular reviewer of over 70 manuscripts for multiple international journals (including BBB, Cancers, Cell Chem Biol, CMLS, FASEB J, FEBS J, J Cell Science, Mol Cell Biol, Mol Cancer, NAR Cancer, Oncogene, PLoS One, RNA, Theranostics, TIBS) various
Distinctions

Title

2020 Re-election as President of the Scientific Council of my institution
Instituto Nacional de Saúde Doutor Ricardo Jorge IP, Portugal

Other distinction

2023 elected President of the Portuguese Society of Human Genetics
Sociedade Portuguesa de Genética Humana, Portugal